Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
1991
Treatment of non-steroidal anti-inflammatory drug induced enteropathy.
1990
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
2008 Standout
Genetically based resistance to the antiinflammatory effects of methotrexate in the air‐pouch model of acute inflammation
2005
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Cancer Pharmacogenomics in Children: Research Initiatives and Progress to Date
2013
Misoprostol reduces indomethacin-induced changes in human small intestinal permeability
1989
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Rheumatoid arthritis
2018 Standout
Parkinson's disease
2021 Standout
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Anti-TNF-α Antibody Therapies in Autoimmune Diseases
2006
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
2017
Adalimumab safety in global clinical trials of patients with Crohnʼs disease
2009
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
1993
Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab
2009
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2
2000 StandoutNobel
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis
2007
Juvenile idiopathic arthritis
2007 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
2005 Standout
The Changing Gastrointestinal Side Effect Profile of Non-Steroidal Anti-Inflammatory Drugs: A New Approach for the Prevention of a New Problem
1989
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
Delayed Induction, Not Impaired Recruitment, of Specific CD8+ T Cells Causes the Late Onset of Acute Hepatitis C
2011 StandoutNobel
An update on methotrexate
2009
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C
2006
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Chapter 4 Biomarkers Of Liver Fibrosis
2008
Safety issues with biological therapies for inflammatory bowel disease
2006
Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma
2011
Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX
2008
The development of molecular clamps as drugs
2006
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation
2007
Helping the mucosa make sense of macromolecules.
1987
Effect of Solar Particle Event Radiation on Gastrointestinal Tract Bacterial Translocation and Immune Activation
2011 StandoutNobel
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
A novel panel of blood markers to assess the degree of liver fibrosis†
2005
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue
2011
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
2005
Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study
2014
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
FIB-4
2007 Standout
Phase II trial of methotrexate in myasthenia gravis
2012
Apoptosis as a Therapeutic Tool in IBD?
2006
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Noninvasive Measures of Liver Fibrosis
2006
Prostate-specific antigen
2000
Infliximab for juvenile idiopathic arthritis‐associated uveitis
2005
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Do We Still Need a Liver Biopsy? Are the Serum Fibrosis Tests Ready for Prime Time?
2006
Management of Crohn's Disease in Adults
2009 Standout
Safety and tolerability of concurrent natalizumab treatment for patients with Crohnʼs disease not in remission while receiving infliximab
2006
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
2011 Standout
Adalimumab induction therapy for ulcerative colitis with intolerance or lost response to infliximab: An open-label study
2007
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography
2008
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients.
1996 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis
2018
Noninvasive markers of hepatic fibrosis: Are they ready for prime time in the management of HIV/HCV co-infected patients?
2005
Liver fibrosis
2008
Recognition between V- and dumbbell-shaped molecules
2013 StandoutNobel
Interventions for enhancing medication adherence
2008 Standout
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
2010
Inflammatory Bowel Disease
2010 Standout
Hepascore: An Accurate Validated Predictor of Liver Fibrosis in Chronic Hepatitis C Infection
2005
Interventions for enhancing medication adherence
2014 Standout
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial
2001
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Genetics of Rheumatoid Arthritis — A Comprehensive Review
2013
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab
2007
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study.
1992
Glucose and citrate reduce the permeability changes caused by indomethacin in humans
1992
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
2013
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
2011
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Katie Smith being referenced
MDDScore
2015
Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients
2006
Assessment of FIBROSpect II to Detect Hepatic Fibrosis in Chronic Hepatitis C Patients
2007
A Pilot Study of Adalimumab in Infliximab-Allergic Patients
2004
Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients
2004
Risk genotypes in folate‐dependent enzymes and their association with methotrexate‐related side effects in rheumatoid arthritis
2006
A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma
2008
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis
2004
Contribution of common polymorphisms in reduced folate carrier and ??-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis
2004
Biological Variation of Prostate Specific Antigen Levels In Serum: An Evaluation of Day-to-Day Physiological Fluctuations in a Well-Defined Cohort of 24 Patients
1997
HPLC Determination of Erythrocyte Methotrexate Polyglutamates after Low-Dose Methotrexate Therapy in Patients with Rheumatoid Arthritis
2003
Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
1984
Prospective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic Biopsy.
2007
111INDIUM-LABELLED POLYMORPHONUCLEAR LEUCOCYTE SCANS IN RHEUMATOID ARTHRITIS—AN IMPORTANT CLINICAL CAUSE OF FALSE POSITIVE RESULTS
1986